NO871352L - Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer. - Google Patents

Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer.

Info

Publication number: NO871352L
Authority: NO; Norway
Prior art keywords: human tumor; procedures; mixtures; identification; disclosed
Prior art date: 1986-04-01

Application number

NO87871352A

Other languages

English (en)

Other versions

NO175642B (no

NO871352D0 (no

NO175642C (no

Inventor

Garth L Nicolson

Susan M North

Peter A Steck

Original Assignee

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-04-01

Filing date

1987-03-31

Publication date

1987-10-02

1987-03-31 Application filed by Univ Texas filed Critical Univ Texas

1987-03-31 Publication of NO871352D0 publication Critical patent/NO871352D0/no

1987-10-02 Publication of NO871352L publication Critical patent/NO871352L/no

1994-08-01 Publication of NO175642B publication Critical patent/NO175642B/no

1994-11-09 Publication of NO175642C publication Critical patent/NO175642C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Stereophonic System (AREA)
Communication Control (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Prostheses (AREA)
Air Conditioning Control Device (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Radar Systems Or Details Thereof (AREA)

NO871352A 1986-04-01 1987-03-31 Hovedsakelig rent humant tumor gp580 antigen, fremgangsmåte for fremstilling derav, antistoff mot dette, kontinuerlig hybrid cellelinje som produserer antistoffet og anvendelse av antistoffet ved in vitro diagnose NO175642C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/846,938 US5030559A (en)	1986-04-01	1986-04-01	Methods and compositions for the identification of metastatic human tumors

Publications (4)

Publication Number	Publication Date
NO871352D0 NO871352D0 (no)	1987-03-31
NO871352L true NO871352L (no)	1987-10-02
NO175642B NO175642B (no)	1994-08-01
NO175642C NO175642C (no)	1994-11-09

Family

ID=25299361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO871352A NO175642C (no)	1986-04-01	1987-03-31	Hovedsakelig rent humant tumor gp580 antigen, fremgangsmåte for fremstilling derav, antistoff mot dette, kontinuerlig hybrid cellelinje som produserer antistoffet og anvendelse av antistoffet ved in vitro diagnose

Country Status (11)

Country	Link
US (1)	US5030559A (no)
EP (1)	EP0240341B1 (no)
JP (1)	JPH0742320B2 (no)
AT (1)	ATE105569T1 (no)
AU (1)	AU599364B2 (no)
CA (1)	CA1307478C (no)
DE (1)	DE3789781T2 (no)
DK (1)	DK162387A (no)
ES (1)	ES2051737T3 (no)
FI (1)	FI89806C (no)
NO (1)	NO175642C (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE403802B (sv) *	1972-10-10	1978-09-04	Buchegger Masch Reinigung	Anordning for rengoring och avfettning av maskindelar och liknande
US5646004A (en) *	1994-08-31	1997-07-08	Activated Cell Therapy, Inc.	Methods for enriching fetal cells from maternal body fluids
US5648223A (en) *	1994-08-31	1997-07-15	Activated Cell Therapy, Inc.	Methods for enriching breast tumor cells
US5840502A (en) *	1994-08-31	1998-11-24	Activated Cell Therapy, Inc.	Methods for enriching specific cell-types by density gradient centrifugation
US5663051A (en) *	1994-08-31	1997-09-02	Activated Cell Therapy, Inc.	Separation apparatus and method
DE19530273C1 (de) *	1995-08-17	1996-12-12	Univ Eberhard Karls	Antikörper 105A5
DE19530272C1 (de) *	1995-08-17	1996-11-21	Univ Eberhard Karls	Antikörper 103 B2
PL365704A1 (en) *	2000-11-28	2005-01-10	Wyeth	Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
MXPA03004688A (es) *	2000-11-28	2003-09-05	Wyeth Corp	Analisis de expresion de acidos nucleicos y polipeptidos fkbp utiles en diagnostico.
NZ526617A (en) *	2000-11-28	2004-09-24	Wyeth Corp	Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7169722B2 (en) *	2002-01-28	2007-01-30	Guardian Industries Corp.	Clear glass composition with high visible transmittance
US7482116B2 (en)	2002-06-07	2009-01-27	Dna Genotek Inc.	Compositions and methods for obtaining nucleic acids from sputum
WO2008031020A2 (en) *	2006-09-08	2008-03-13	Wyeth	Arginine wash in protein purification using affinity chromatography
US20090324596A1 (en) *	2008-06-30	2009-12-31	The Trustees Of Princeton University	Methods of identifying and treating poor-prognosis cancers
US10745701B2 (en)	2007-06-28	2020-08-18	The Trustees Of Princeton University	Methods of identifying and treating poor-prognosis cancers
BR112013032629A2 (pt)	2011-06-19	2017-08-01	Abogen Inc	dispositivos, soluções e métodos para coletamento de amostra
CN107430105A (zh)	2015-02-09	2017-12-01	阿波根有限公司	用于采集相关应用、分析和诊断的样本的设备、溶液和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3697638A (en) *	1970-06-01	1972-10-10	Hoffmann La Roche	Antigens
US4140753A (en) *	1976-04-30	1979-02-20	Scripps Clinic & Research Foundation	Diagnostic method and reagent
US4145336A (en) *	1976-04-30	1979-03-20	Scripps Clinic And Research Foundation	Carcinoembryonic antigen isomer
IN150740B (no) *	1978-11-24	1982-12-04	Hoffmann La Roche
US4444744A (en) *	1980-03-03	1984-04-24	Goldenberg Milton David	Tumor localization and therapy with labeled antibodies to cell surface antigens
DE3586216T2 (de) *	1984-05-01	1992-12-10	Ciba Corning Diagnostics Corp	Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.

1986
- 1986-04-01 US US06/846,938 patent/US5030559A/en not_active Expired - Fee Related
1987
- 1987-03-30 AU AU70753/87A patent/AU599364B2/en not_active Ceased
- 1987-03-30 CA CA000533286A patent/CA1307478C/en not_active Expired - Lifetime
- 1987-03-31 NO NO871352A patent/NO175642C/no unknown
- 1987-03-31 DK DK162387A patent/DK162387A/da not_active Application Discontinuation
- 1987-03-31 FI FI871411A patent/FI89806C/fi not_active IP Right Cessation
- 1987-04-01 EP EP87302848A patent/EP0240341B1/en not_active Expired - Lifetime
- 1987-04-01 AT AT8787302848T patent/ATE105569T1/de not_active IP Right Cessation
- 1987-04-01 ES ES87302848T patent/ES2051737T3/es not_active Expired - Lifetime
- 1987-04-01 JP JP62080856A patent/JPH0742320B2/ja not_active Expired - Lifetime
- 1987-04-01 DE DE3789781T patent/DE3789781T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US5030559A (en)	1991-07-09
DE3789781T2 (de)	1994-11-10
CA1307478C (en)	1992-09-15
EP0240341B1 (en)	1994-05-11
DK162387A (da)	1987-10-02
FI89806B (fi)	1993-08-13
DE3789781D1 (de)	1994-06-16
AU599364B2 (en)	1990-07-19
EP0240341A3 (en)	1989-07-19
NO175642B (no)	1994-08-01
ATE105569T1 (de)	1994-05-15
JPS62253395A (ja)	1987-11-05
FI89806C (fi)	1993-11-25
NO871352D0 (no)	1987-03-31
AU7075387A (en)	1987-10-08
NO175642C (no)	1994-11-09
JPH0742320B2 (ja)	1995-05-10
FI871411L (fi)	1987-10-02
ES2051737T3 (es)	1994-07-01
EP0240341A2 (en)	1987-10-07
FI871411A0 (fi)	1987-03-31
DK162387D0 (da)	1987-03-31

Publication	Publication Date	Title
NO871352L (no)	1987-10-02	Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer.
EP0288082A3 (en)	1989-11-29	A tumor specific assay for ca125 ovarian cancer antigen
WO1999004265A8 (en)	1999-05-14	Cancer associated nucleic acids and polypeptides
FI92258B (fi)	1994-06-30	Onkostatiini-A:n käyttö diagnostisessa menetelmässä
WO2000036107A3 (en)	2001-02-22	Compositions and methods for therapy and diagnosis of ovarian cancer
EP1630235A3 (en)	2009-05-27	Compounds for immunodiagnosis of prostate cancer and method for their use
NO960925D0 (no)	1996-03-07	Diagnostiske, prognostiske og terapeutiske metoder for faste, ikke-lymfoide tumorer og deres metastaser
AU6785987A (en)	1987-07-30	Selecting and testing antibodies for cancer therapy
OA08485A (fr)	1988-07-29	Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
NO885013D0 (no)	1988-11-10	Fremgangsmte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppndd ved fremgangsmten.
EP0163303A3 (en)	1987-11-25	Human monoclonal antibodies to cell surface and intracellular antigens
GB2182949A (en)	1987-05-28	Monoclonal antibodies and antigens for human non-small cell lung carcinomas
CA2207505A1 (en)	1997-04-24	Neurological drug screens
DK0454782T3 (da)	1997-10-27	Cancer-beslægtet haptaglobin (Hpr.)
IE802533L (en)	1981-07-04	Cancer cell antigens
WO1999000671A3 (en)	1999-06-10	Method for identification of tumor antigens with autoantibodies in serum
AU2883597A (en)	1998-01-05	Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
WO1991017187A3 (en)	1991-12-26	A 35kd tumor associated protein antigen: uses and methods of detection
DE3582191D1 (de)	1991-04-25	Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
ØRJASæTER	1976	STUDY OF SUBSTANCES RELATED TO CARCINOEMBRYONIC ANTIGENS, CEA‐NCA AND ASSOCIATION WITH α1‐ANTICHYMOTRYPSIN
NZ333075A (en)	2000-05-26	isolated protein markers for use in diagnosing esophageal cancer
AU5752490A (en)	1990-10-04	A novel tumor associated antigen
NO914094L (no)	1991-10-17	Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer
NO873274L (no)	1988-02-08	Tettet roerskjoet og fremgangsmaate for dannelse av denne.
NO894332D0 (no)	1989-10-31	Fremgangsmaate for fremstilling av metanol og katalysator for denne.